{"id":"https://openalex.org/W7225176304","doi":"https://doi.org/10.2147/dddt.s650566","title":"CEACAM5-Targeted Therapies in Solid Tumors: Biological Barriers and Next-Generation Precision Strategies","display_name":"CEACAM5-Targeted Therapies in Solid Tumors: Biological Barriers and Next-Generation Precision Strategies","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225176304","doi":"https://doi.org/10.2147/dddt.s650566","pmid":"https://pubmed.ncbi.nlm.nih.gov/42999607","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13744187"},"language":"en","primary_location":{"id":"doi:10.2147/dddt.s650566","doi":"https://doi.org/10.2147/dddt.s650566","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s650566","pdf_url":"https://www.dovepress.com/article/download/121802","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/article/download/121802","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5136235737","display_name":"Tingting Ye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113195","display_name":"Gannan Medical University","ror":"https://ror.org/01tjgw469","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210113195"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tingting Ye","raw_affiliation_strings":["School of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, People's Republic of China","institution_ids":["https://openalex.org/I4210113195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160425594","display_name":"Ruohan Mei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113195","display_name":"Gannan Medical University","ror":"https://ror.org/01tjgw469","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210113195"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ruohan Mei","raw_affiliation_strings":["The First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi, 341000, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi, 341000, People's Republic of China","institution_ids":["https://openalex.org/I4210113195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5144063298","display_name":"Xiaoting Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113195","display_name":"Gannan Medical University","ror":"https://ror.org/01tjgw469","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210113195"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaoting Liu","raw_affiliation_strings":["The First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi, 341000, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi, 341000, People's Republic of China","institution_ids":["https://openalex.org/I4210113195"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040117776","display_name":"Panpan Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113195","display_name":"Gannan Medical University","ror":"https://ror.org/01tjgw469","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210113195"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Panpan Huang","raw_affiliation_strings":["School of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, People's Republic of China","institution_ids":["https://openalex.org/I4210113195"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210113195"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.52573529,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"Volume 20","issue":null,"first_page":"1","last_page":"27"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5297999978065491,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5297999978065491,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.12839999794960022,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.04580000042915344,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceacam5","display_name":"CEACAM5","score":1.0},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.7459999918937683},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8299999833106995},{"id":"https://openalex.org/keywords/glycosylation","display_name":"glycosylation","score":0.6439999938011169},{"id":"https://openalex.org/keywords/antigenic-diversity","display_name":"antigenic diversity","score":0.8619999885559082},{"id":"https://openalex.org/keywords/immunosuppressive-tumor-microenvironment","display_name":"immunosuppressive tumor microenvironment","score":0.9120000004768372},{"id":"https://openalex.org/keywords/biomarker-guided-patient-selection","display_name":"biomarker-guided patient selection","score":0.7829999923706055},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.4869000017642975},{"id":"https://openalex.org/C2777387746","wikidata":"https://www.wikidata.org/wiki/Q769706","display_name":"Carcinoembryonic antigen","level":3,"score":0.4846000075340271},{"id":"https://openalex.org/C188198153","wikidata":"https://www.wikidata.org/wiki/Q1613840","display_name":"Limiting","level":2,"score":0.4790000021457672},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.478300005197525},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.46700000762939453},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.42739999294281006},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3714999854564667},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.3508000075817108},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3506999909877777},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.3504999876022339},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3416000008583069},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3314000070095062},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.31709998846054077},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3142000138759613},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.2985000014305115},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.27730000019073486},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.27390000224113464},{"id":"https://openalex.org/C3020792226","wikidata":"https://www.wikidata.org/wiki/Q1331083","display_name":"Human use","level":2,"score":0.26750001311302185},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2671000063419342},{"id":"https://openalex.org/C16224149","wikidata":"https://www.wikidata.org/wiki/Q187637","display_name":"Cell adhesion molecule","level":2,"score":0.2639999985694885},{"id":"https://openalex.org/C3019692148","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Therapeutic modalities","level":2,"score":0.26179999113082886},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.26170000433921814},{"id":"https://openalex.org/C2908701176","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biological drugs","level":3,"score":0.2567000091075897}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002272","descriptor_name":"Carcinoembryonic Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058851","descriptor_name":"GPI-Linked Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.2147/dddt.s650566","doi":"https://doi.org/10.2147/dddt.s650566","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s650566","pdf_url":"https://www.dovepress.com/article/download/121802","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},{"id":"pmid:42999607","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42999607","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug design, development and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:27c07584c54a49d5b72d25add66ac287","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/27c07584c54a49d5b72d25add66ac287","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Drug Design, Development and Therapy, Vol Volume 20, Iss Issue 1, Pp 1-27 (2026)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/121802","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/ceacam5-targeted-therapies-in-solid-tumors-biological-barriers-and-nex-peer-reviewed-fulltext-article-DDDT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Review"}],"best_oa_location":{"id":"doi:10.2147/dddt.s650566","doi":"https://doi.org/10.2147/dddt.s650566","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s650566","pdf_url":"https://www.dovepress.com/article/download/121802","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6419683083","display_name":null,"funder_award_id":"82560532","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225176304.pdf","grobid_xml":"https://content.openalex.org/works/W7225176304.grobid-xml"},"referenced_works_count":96,"referenced_works":["https://openalex.org/W14783117","https://openalex.org/W1487353108","https://openalex.org/W1978191585","https://openalex.org/W1983143892","https://openalex.org/W1987516241","https://openalex.org/W1989402502","https://openalex.org/W2004102690","https://openalex.org/W2014187441","https://openalex.org/W2021396643","https://openalex.org/W2044912383","https://openalex.org/W2046975598","https://openalex.org/W2061537048","https://openalex.org/W2063303727","https://openalex.org/W2066594663","https://openalex.org/W2087392940","https://openalex.org/W2087595621","https://openalex.org/W2095131825","https://openalex.org/W2100784663","https://openalex.org/W2105184527","https://openalex.org/W2109853804","https://openalex.org/W2115140837","https://openalex.org/W2139846940","https://openalex.org/W2140884608","https://openalex.org/W2160100004","https://openalex.org/W2164313302","https://openalex.org/W2169003399","https://openalex.org/W2169772835","https://openalex.org/W2280885574","https://openalex.org/W2463872312","https://openalex.org/W2484886006","https://openalex.org/W2597946622","https://openalex.org/W2634656227","https://openalex.org/W2746753615","https://openalex.org/W2773065484","https://openalex.org/W2782307120","https://openalex.org/W2789862753","https://openalex.org/W2855118459","https://openalex.org/W2885037769","https://openalex.org/W2913927155","https://openalex.org/W2946884236","https://openalex.org/W2947877311","https://openalex.org/W2974224972","https://openalex.org/W2978301128","https://openalex.org/W3029573274","https://openalex.org/W3080292686","https://openalex.org/W3107681451","https://openalex.org/W3111689114","https://openalex.org/W3134299762","https://openalex.org/W3137084362","https://openalex.org/W4205228191","https://openalex.org/W4220864880","https://openalex.org/W4220973444","https://openalex.org/W4283774589","https://openalex.org/W4311666520","https://openalex.org/W4319947133","https://openalex.org/W4362535904","https://openalex.org/W4362588522","https://openalex.org/W4379800141","https://openalex.org/W4386189919","https://openalex.org/W4386399140","https://openalex.org/W4387893906","https://openalex.org/W4388119899","https://openalex.org/W4388665568","https://openalex.org/W4389138262","https://openalex.org/W4389616058","https://openalex.org/W4389819254","https://openalex.org/W4390612337","https://openalex.org/W4390906610","https://openalex.org/W4393085726","https://openalex.org/W4394909281","https://openalex.org/W4395078985","https://openalex.org/W4396934258","https://openalex.org/W4400047071","https://openalex.org/W4402755038","https://openalex.org/W4403410419","https://openalex.org/W4403745600","https://openalex.org/W4403890164","https://openalex.org/W4404975982","https://openalex.org/W4406389444","https://openalex.org/W4406869334","https://openalex.org/W4409633144","https://openalex.org/W4409634333","https://openalex.org/W4410814844","https://openalex.org/W4410859389","https://openalex.org/W4412759926","https://openalex.org/W4414085736","https://openalex.org/W4415520759","https://openalex.org/W4415789276","https://openalex.org/W4415998944","https://openalex.org/W4416536284","https://openalex.org/W7083629001","https://openalex.org/W7125510726","https://openalex.org/W7127971180","https://openalex.org/W7131784367","https://openalex.org/W7147711212","https://openalex.org/W7148928433"],"related_works":["https://openalex.org/W3029573274","https://openalex.org/W4294942233","https://openalex.org/W7127971180","https://openalex.org/W4408979012","https://openalex.org/W2563206586","https://openalex.org/W4387812584","https://openalex.org/W7169560794","https://openalex.org/W4296012076","https://openalex.org/W2762023112","https://openalex.org/W4404005516"],"abstract_inverted_index":{"Carcinoembryonic":[0],"antigen-related":[1],"cell":[2],"adhesion":[3],"molecule":[4],"5":[5],"(CEACAM5)":[6],"is":[7],"an":[8],"attractive":[9],"therapeutic":[10,109,167],"target":[11,83,164],"because":[12],"of":[13,48,97],"its":[14,21],"widespread":[15],"overexpression":[16],"in":[17,26,62,73,99],"epithelial":[18],"malignancies":[19],"and":[20,125,151,166,176],"polarised,":[22],"largely":[23],"luminal":[24],"expression":[25,84,162],"normal":[27],"epithelium.":[28],"Despite":[29],"extensive":[30,121],"clinical":[31,153],"development,":[32],"no":[33],"CEACAM5-targeted":[34,74],"drug":[35],"has":[36],"received":[37],"regulatory":[38],"approval.":[39],"The":[40],"Phase":[41],"III":[42],"CARMEN-LC03":[43],"trial":[44,154],"highlighted":[45],"the":[46,58,87,94,104],"limitations":[47],"expression-based":[49],"patient":[50,157],"selection,":[51],"as":[52],"tusamitamab":[53],"ravtansine":[54],"failed":[55],"to":[56,85,170,174],"improve":[57],"ORR":[59],"over":[60],"docetaxel":[61],"patients":[63,172],"with":[64,163],"high":[65],"CEACAM5":[66,98,161],"expression.":[67],"This":[68],"review":[69],"argues":[70],"that":[71],"progress":[72],"therapy":[75],"requires":[76],"a":[77],"shift":[78],"from":[79],"focusing":[80],"solely":[81],"on":[82,130],"understanding":[86],"target's":[88],"biological":[89,95,106,132],"constraints.":[90],"We":[91],"first":[92],"summarize":[93],"functions":[96],"tumor":[100,127],"progression,":[101],"then":[102],"discuss":[103],"major":[105],"barriers":[107],"limiting":[108],"efficacy":[110],"including":[111],"GPI":[112],"anchor-mediated":[113],"slow":[114],"internalization,":[115],"soluble":[116],"CEACAM5-mediated":[117],"antigen":[118,123],"sink":[119],"effects,":[120],"glycosylation,":[122],"heterogeneity,":[124],"immunosuppressive":[126],"microenvironment.":[128],"Building":[129],"these":[131],"barriers,":[133],"we":[134],"outline":[135],"five":[136],"priorities":[137],"for":[138],"next-generation":[139],"development:":[140],"targeting":[141],"tumor-specific":[142],"glycoforms,":[143],"multi-antigen":[144],"strategies,":[145],"microenvironment":[146],"remodeling,":[147],"conditionally":[148],"restricted":[149],"delivery,":[150],"biomarker-guided":[152],"design.":[155],"Future":[156],"selection":[158],"should":[159],"integrate":[160],"biology":[165],"modality":[168],"compatibility":[169],"identify":[171],"likely":[173],"benefit":[175],"reduce":[177],"ineffective":[178],"treatment.":[179]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-04T00:00:00"}